Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BYHAUGEN LEGESENTER AS
AS
Active
Org 995385775
Randabergveien 45, 4025 Stavanger
General medical practice activities · NACE 8621
Est. 2010
5 employees
www.byhaugen.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 4,9M
-1% vs 2024
EBITDA margin
0.4%
-94% vs 2024
Equity ratio
18.7%
Financial strength
Net profit 2025
NOK -29K
-113% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 4,9M
-1%
EBITDA
NOK 17K
-94%
Net profit
NOK -29K
-113%
Total assets
NOK 726K
+5%
Equity
NOK 135K
-18%
Employees
5
—
Company information
Legal name
BYHAUGEN LEGESENTER AS
Org number
995385775
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. april 2010
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Daglig leder alene. Styrets leder alene.
Company purpose
Fastlegedrift og andre produkter/tjenester som naturlig hører sammen med dette.
Contact
Address
Randabergveien 45, 4025 Stavanger
Phone
+4740005343
Email
oslo@sthanshaugenlegesenter.nhn
Website
www.byhaugen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
4M
2021
4M
2022
5M
2023
5M
2024
5M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
3 891
3 993
4 601
4 960
4 897
Staff expenses
−1 871
−2 015
−2 059
−2 140
−2 298
EBITDA
142
−184
105
272
17
Depreciation & amort.
−27
−32
−36
−46
−46
EBIT
115
−216
69
226
−29
Net financials
−0
−0
0
−0
0
Profit before tax
115
−217
69
225
−29
Tax
−0
−0
−0
−0
−0
Net profit
115
−217
69
225
−29
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
611
467
549
692
726
Equity
87
−130
−61
164
135
Long-term debt
0
0
0
0
0
Short-term debt
524
596
610
527
591
Total debt
524
596
610
527
591
Financial ratios
5-year trend
EBITDA margin
0.4%
This company
15.8%
Market median
-97% vs market
2021
2025
Equity ratio
18.7%
This company
38.2%
Market median
-51% vs market
2021
2025
Return on equity
-21.3%
This company
18.4%
Market median
-216% vs market
2021
2025
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
2021
2025
Asset turnover
6.74×
This company
1.12×
Market median
+502% vs market
2021
2025
Debt / equity
4.36×
This company
0.62×
Market median
-603% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Petter Enoksen
Individual
20%
20%
2024
Eirik Viste
Individual
20%
20%
2024
Møyfrid Müller
Individual
20%
20%
2024
Steven David Gang'Ai
Individual
20%
20%
2024
Stine Wiedswang
Individual
20%
20%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BYHAUGEN LEGESENTER AS also hold positions in
0
other companies.
Person
Role here
Other companies